-->

Type something and hit enter

On

 




Ho Wah Genting Berhad (HWGB) is an investment holding company founded by Hui Boon Lim on 12 August 1993, and is headquartered in Kuala Lumpur. HWGB is primarily involved in the provision of management services. 

The company’s segments include Investment, Moulded Power Supply Cord sets, Wires and Cables, Automotive, Mining, Travelling services and Direct Selling. The investment segments comprise of investments in properties and investment by holding company. The Moulded power supply cord sets segment is engaged in manufacturing and trading of wires and cables, moulded power supply cord sets and cable assemblies for electrical and electronic devices and equipment. The wires and cables segment are engaged in trading of wires and cables. The Automotive segment is engaged in trading of motor vehicles. The Mining segment is engaged in tin mining and its related activities. The travelling services segment includes travel agent and tour related services. The Direct Selling segment is engaged in selling of travelling kits.

HWGB announced that it had entered into an agreement memorandum through its wholly-owned subsidiary HWGB Biotech Sdn Bhd (HWGB Biotech) and US-based E-MO Biology Inc (EBI) to undertake research on Covid-19 patent applications. Both of them are interested in collaborating with the new phase of poliomyelitis vaccine trial plan for the fourth phase of the new crown vaccine.

According to the HWGB Biotech Sdn Bhd, they plan to invest US $1 million (about RM4.19 million) into E-MO biology, which will make 40% profit from the commercialization of vaccines. Based on a general executive of the company, Lim Wei Xiong said would cooperate with the new crown vaccine to make it available as soon as possible and to make it affordable to the public.

Once it is implemented, the novel coronavirus pneumonia will have exclusive rights to produce, distribute and sell vaccines based on the polio vaccine. The vaccine can be used to prevent novel pneumonia infection in Southeast Asian countries and retain all profits, while enjoying% if the net profit of emo-biology.